Literature DB >> 27280773

Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01.

Beatriz Vera, Naiara Martínez-Vélez, Enric Xipell, Arlet Acanda de la Rocha, Ana Patiño-García, Javier S Castresana, Marisol Gonzalez-Huarriz, Manel Cascallo, Ramón Alemany, Marta M Alonso.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0147211.].

Entities:  

Year:  2016        PMID： 27280773      PMCID： PMC4900591          DOI： 10.1371/journal.pone.0157619

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The sixth author’s name is misspelled. The correct name is: Javier S. Castresana. The correct citation is: Vera B, Martínez-Vélez N, Xipell E, Acanda de la Rocha A, Patiño-García A, Castresana JS, et al. (2016) Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01. PLoS ONE 11(1): e0147211. doi:10.1371/journal.pone.0147211
  1 in total

1.  Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01.

Authors:  Beatriz Vera; Naiara Martínez-Vélez; Enric Xipell; Arlet Acanda de la Rocha; Ana Patiño-García; Javier Saez-Castresana; Marisol Gonzalez-Huarriz; Manel Cascallo; Ramón Alemany; Marta M Alonso
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240
  1 in total
  1 in total

1.  Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus.

Authors:  Ahmed Abdullah Al-Zaher; Rafael Moreno; Carlos Alberto Fajardo; Marcel Arias-Badia; Martí Farrera; Jana de Sostoa; Luis Alfonso Rojas; Ramon Alemany
Journal:  Mol Ther Oncolytics       Date:  2018-01-31       Impact factor: 7.200
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.